
MARTINA
STEINER
Profesora
Publications (34) MARTINA STEINER publications
2025
-
Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
Pharmaceuticals, Vol. 18, Núm. 1
2024
-
An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis
Journal of Clinical Medicine, Vol. 13, Núm. 5
-
Espondiloartritis juvenil. Artritis relacionada con entesitis
Manual SER de diagnóstico y tratamiento en reumatología pediátrica (Ergon), pp. 105-110
-
Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Medicina Clinica, Vol. 162, Núm. 10, pp. 470-476
-
Raynaud's phenomenon and digital ischaemia induced by ixekizumab
Rheumatology (Oxford, England), Vol. 63, Núm. 1
2023
-
AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907
-
POS0793-HPR Observational Study in Real Clinical Practice of the Treatment of Non-Infectious Uveitis (PÓSTER)
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 689.2-690
-
Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625
-
The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors
Vaccines, Vol. 11, Núm. 10
2022
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 28, Núm. 2, pp. e348-e352
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352
2021
-
Impact of biological therapies on the immune response after pneumococcal vaccination in patients with autoimmune inflammatory diseases
Vaccines, Vol. 9, Núm. 3, pp. 1-12
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
-
Protocolised odontological assessment of patients with primary Sjögren's syndrome
Reumatologia Clinica, Vol. 17, Núm. 1, pp. 25-31
-
Reply
Medicina Clinica
-
Serological response to influenza vaccine in patients with autoimmune inflammatory diseases: Results of RIER study
Medicina Clinica, Vol. 156, Núm. 3, pp. 118-122
2020
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
-
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study
Clinical Rheumatology, Vol. 39, Núm. 9, pp. 2751-2756
-
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study
Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828
-
Reproducibilidad de la medición manual del grosor coroideo utilizando la tomografía de coherencia óptica
Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 8, pp. 379-385